Graf Akcie SNY (Sanofi). Diskuze k akciím SNY. Aktuální informace SNY.

Základní informace o společnosti Sanofi (Akcie SNY)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace
Hodnota podniku (EV)
Tržby
EBITDA
Zisk
Růst v tržbách Q/Q %
Růst v tržbách Y/Y %
P/E (Cena vůči ziskům)
Forward P/E
EV/Sales
EV/EBITDA
EV/EBIT
PEG
Price/Sales
P/FCF
Price/Book
Účetní hodnota na akcii
Hotovost na akcii
FCF vůči ceně %
Počet zaměstnanců
Tržba na zaměstnance
Profit margin %
Operating margin %
Gross margin %
EBIT margin %
EBITDA margin %
EPS - Zisk na akcii
EPS - Kvartální růst %
EPS - Očekávaný růst příští rok %
Return on assets %
Return on equity %
ROIC %
ROCE %
Dluhy/Equity
Čistý dluh/EBITDA
Current ratio
Quick Ratio
Volatilita
Beta
RSI
Cílová cena analytiků
Známka akcie (dle analytiků)
Insider ownership %
Institutional ownership %
Počet akcií
Procento shortovaných akcií %
Short ratio %
Dividenda
Procentuální dividenda %
Dividenda/Zisk %
Obchodovaná od
Země

Finanční výsledky akcie SNY

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$42,686.61$42,146.72$42,134.54$40,921.38$38,407.87$38,709.66
Cost Of Goods Sold$13,886.94$13,413.12$13,504.74$13,123.91$11,842.83$12,124.46
Gross Profit$28,799.67$28,733.6$28,629.8$27,797.47$26,565.04$26,585.2
Research And Development Expenses$6,315.777$6,740.16$6,960.814$6,185.001$5,723.335$5,643.053
SG&A Expenses$10,726.2$11,068.96$11,643.48$11,368.56$10,497.21$10,417.77
Other Operating Income Or Expenses$7,766.499$-61.6$517.278$-238.493$92.954$-230.963
Operating Expenses$26,298.03$34,876.8$35,902.4$33,851.36$30,815.49$31,671.94
Operating Income$16,388.58$7,269.914$6,232.137$7,070.027$7,592.383$7,037.719
Total Non-Operating Income/Expense$-620.269$-4,109.28$-1,029.832$-819.468$-1,309.108$-1,215.888
Pre-Tax Income$15,768.31$3,160.64$5,202.305$6,250.559$6,283.275$5,821.827
Income Taxes$2,070.99$155.68$568.061$1,946.377$1,467.352$787.274
Income After Taxes$13,697.32$3,004.96$4,634.244$4,304.183$4,815.923$5,034.554
Other Income------
Income From Continuous Operations$14,107.41$3,290.56$5,223.563$4,421.734$4,964.208$5,010.125
Income From Discontinued Operations------
Net Income$14,066.28$3,142.72$5,085.386$9,532.95$5,210.979$4,760.285
EBITDA$16,388.58$15,616.15$11,285.64$11,236.31$11,245.27$11,785.79
EBIT$16,388.58$7,269.914$6,232.137$7,070.027$7,592.383$7,037.719
Basic Shares Outstanding2,5072,5002,4942,5142,5732,612
Shares Outstanding2,5072,5142,5102,5342,5922,641
Basic EPS$5.61$1.25$2.04$3.79$2.02$1.82
EPS - Earnings Per Share$5.61$1.25$2.02$3.76$2.01$1.80
# 2020 2019 2018 2017 2016 2015
Current Ratio1.40381.41451.70491.62391.48161.7977
Long-term Debt / Capital0.25410.27160.19740.22560.18390.1909
Debt/Equity Ratio0.41760.41740.26780.32190.28440.2633
Gross Margin68.175267.948667.92969.165668.678567.6654
Operating Margin17.249114.79117.277119.767818.180818.822
EBIT Margin17.249114.79117.277119.767818.180818.822
EBITDA Margin37.051926.784827.458329.278630.446629.8953
Pre-Tax Profit Margin7.499112.346915.274616.359315.039716.802
Net Profit Margin7.456612.069423.295813.567512.297412.8705
Asset Turnover0.33380.32020.36270.33160.34070.3502
Inventory Turnover Ratio1.49811.52941.70351.55281.67571.6807
Receiveable Turnover4.74124.91425.01724.74744.71994.7712
Days Sales In Receivables76.984574.274772.7576.884777.332576.5014
ROE - Return On Equity4.97067.49226.7157.77157.75128.0134
Return On Tangible Equity-148.1593-62.392479.609368.40568.0851178.362
ROA - Return On Assets2.60613.97013.91884.28584.40974.6297
ROI - Return On Investment3.70785.45775.38966.01836.32576.4837
Book Value Per Share26.399627.989926.259424.719924.751728.3458
Operating Cash Flow Per Share0.8402-0.6825-0.0543-0.1387-0.35480.3862
Free Cash Flow Per Share0.48890.03910.11180.1378-0.78830.2343